Barriers to Optimal Care for Patients with Coexisting Substance Use and Mental Health Disorders

2002 ◽  
Vol 36 (6) ◽  
pp. 792-799 ◽  
Author(s):  
Fraser C. Todd ◽  
J. Douglas Sellman ◽  
Paul J. Robertson

Objective: This paper describes qualitative research that was carried out as part of a project aimed at drawing up a series of guidelines for the assessment and management for people with coexisting substance use and mental health disorders, or dual diagnosis [ 1 ]. Method: A core consultation team of 14 experts with experience in the areas of both substance use and mental health in New Zealand was established to advise on the development of eight clinical scenarios. The clinical scenarios were selected to highlight a range of real life issues in the treatment of people with coexisting substance use and mental health disorders and were presented at 12 focus groups around New Zealand. The 261 participants of the focus groups were asked to comment on what was optimal management for each of the scenarios and to identify barriers to optimal care in their region. Written notes were analysed for recurring and strongly stated themes and these comprise the results of the study. Results: While there was marked regional variation in treatment approaches and service structures, many of the barriers to optimal care that were identified were common to all regions. The results are considered under the headings of systems issues, clinical issues and attitudes. Conclusions: A wide variety of barriers that impede the delivery of optimal care have been identified. These range from the attitudes of individual clinicians to the structure of the systems within which they work. A system of key principles and processes for organizing treatment in a way which helps overcome these barriers is proposed.

2019 ◽  
Vol 19 (9) ◽  
pp. S111-S112
Author(s):  
Neil V. Shah ◽  
Cameron R. Moattari ◽  
Harleen Kaur ◽  
Adam J. Wolfert ◽  
Sirish Khanal ◽  
...  

2018 ◽  
Vol 7 (12) ◽  
pp. 543 ◽  
Author(s):  
Sarvenaz Esmaeelzadeh ◽  
John Moraros ◽  
Lilian Thorpe ◽  
Yelena Bird

Background: The purpose of this systematic review was to examine the association and directionality between mental health disorders and substance use among adolescents and young adults in the U.S. and Canada. Methods: The following databases were used: Medline, PubMed, Embase, PsycINFO, and Cochrane Library. Meta-analysis used odds ratios as the pooled measure of effect. Results: A total of 3656 studies were screened and 36 were selected. Pooled results showed a positive association between depression and use of alcohol (odds ratio (OR) = 1.50, 95% confidence interval (CI): 1.24–1.83), cannabis (OR = 1.29, 95% CI: 1.10–1.51), and tobacco (OR = 1.65, 95% CI: 1.43–1.92). Significant associations were also found between anxiety and use of alcohol (OR = 1.54, 95% CI: 1.19–2.00), cannabis (OR = 1.36, 95% CI: 1.02–1.81), and tobacco (OR = 2.21, 95% CI: 1.54–3.17). A bidirectional relationship was observed with tobacco use at baseline leading to depression at follow-up (OR = 1.87, CI = 1.23–2.85) and depression at baseline leading to tobacco use at follow-up (OR = 1.22, CI = 1.09–1.37). A unidirectional relationship was also observed with cannabis use leading to depression (OR = 1.33, CI = 1.19–1.49). Conclusion: This study offers insights into the association and directionality between mental health disorders and substance use among adolescents and young adults. Our findings can help guide key stakeholders in making recommendations for interventions, policy and programming.


2020 ◽  
Vol 91 (8) ◽  
pp. e3.2-e3
Author(s):  
Daniel Freeman

Daniel Freeman is an NIHR Research Professor and Professor of Clinical Psychology in the Department of Psychiatry, University of Oxford, a consultant clinical psychologist in Oxford Health NHS Foundation Trust, a fellow of University College Oxford, and leads the Oxford Cognitive Approaches to Psychosis (O-CAP) research group at the University of Oxford.Daniel has been working with virtual reality (VR) since 2001 and is a founder of Oxford VR, a University of Oxford spinout company.Mental health disorders are very common, but far too few people receive the best treatments. Much greater access to the best psychological treatments may be achieved using automated delivery in virtual reality (VR). With virtual reality simulations, individuals can repeatedly experience problematic situations and be taught, via evidence-based psychological treatments, how to overcome difficulties. A key advantage of VR is that individuals know that a computer environment is not real but their minds and bodies behave as if it is real; hence, people will much more easily face difficult situations in VR than in real life and be able to try out new therapeutic strategies. VR treatments can also be made much more engaging and appealing for patients than traditional therapies. A systematic programme of work developing and testing automated VR psychological treatments will be described, with a particular focus on the gameChange (www.gameChangeVR.com) project for schizophrenia.


AIDS Care ◽  
2019 ◽  
Vol 31 (8) ◽  
pp. 923-931 ◽  
Author(s):  
Khem Narayan Pokhrel ◽  
Kalpana Gaulee Pokhrel ◽  
Vidya Dev Sharma ◽  
Krishna Chandra Poudel ◽  
Sanjeev Raj Neupane ◽  
...  

2013 ◽  
Vol 50 (3) ◽  
pp. 288-295 ◽  
Author(s):  
Elizabeth Balyakina ◽  
Christopher Mann ◽  
Michael Ellison ◽  
Ron Sivernell ◽  
Kimberly G. Fulda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document